Get started
VALBIOTISVALBIOTISVALBIOTIS

VALBIOTIS

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

ALVAL chart

Key stats

Market capitalization
‪60.60 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income
‪−12.31 M‬EUR
Revenue
‪785.00 K‬EUR
Shares float
‪15.13 M‬
Beta (1Y)
0.33

About VALBIOTIS

Sector
Health Technology
Industry
Biotechnology
CEO
Sebastien M. Peltier
Website
valbiotis.com
Headquarters
Perigny
Employees (FY)
48
Founded
2014
ISIN
FR0013254851
FIGI
BBG00GQNQWV2
Valbiotis SA develops products and candidate drugs designed to prevent metabolic diseases. The company was founded on December 2, 2014 and is headquartered in Perigny, France.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ALVAL is 3.860 EUR — it has decreased by 0.64% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange VALBIOTIS stocks are traded under the ticker ALVAL.
ALVAL stock is 4.84% volatile and has beta coefficient of 0.33. Check out the list of the most volatile stocks — is VALBIOTIS there?
One year price forecast for VALBIOTIS has a max estimate of 11.800 EUR and a min estimate of 9.200 EUR.
Yes, you can track VALBIOTIS financials in yearly and quarterly reports right on TradingView.
ALVAL stock has fallen by 2.53% compared to the previous week, the month change is a 9.35% rise, over the last year VALBIOTIS has showed a 8.43% increase.
Today VALBIOTIS has the market capitalization of ‪61.29 M‬, it has increased by 10.34% over the last week.
No, ALVAL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALVAL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VALBIOTIS stock right from TradingView charts — choose your broker and connect to your account.
ALVAL reached its all-time high on Jun 14, 2017 with the price of 10.555 EUR, and its all-time low was 1.980 EUR and was reached on Dec 5, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 48.00 employees. See our rating of the largest employees — is VALBIOTIS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VALBIOTIS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VALBIOTIS stock shows the sell signal. See more of VALBIOTIS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on VALBIOTIS future price: according to them, ALVAL price has a max estimate of 11.80 EUR and a min estimate of 9.20 EUR. Read a more detailed VALBIOTIS forecast: see what analysts think of VALBIOTIS and suggest that you do with its stocks.